Introduction
In the rat, the early stage of blastocyst implantation involves cellular adhesion between the tro¬ phectoderm and the luminal epithelium of the uterus, following which the trophoblast penetrates the epithelium and invades the endometrial stroma (Schlafke & Enders, 1975) . A prerequisite for successful implantation is that the endometrium has been sensitized appropriately by ovarian steroid hormones, and this takes place during the reproductive cycle (Casimiri & Psychoyos, 1981; Psychoyos, 1986) . Progesterone must prime the endometrium for some 48 h before oestrogen can induce a short phase of endometrial blastocyst receptivity (Psychoyos & Martel, 1985) .
That cell adhesion involves interactions between specific cell surface molecules is well estab¬ lished (see reviews by Edelman, 1986; Öbrink, 1986) . Previous attempts to characterize cell surface molecules involved in the acquisition of endometrial blastocyst receptivity in the rabbit and mouse have revealed that alterations occur in the glycoprotein composition of the luminal surface of the uterus (Lampelo et ai, 1985; Chávez & Anderson, 1985; Anderson et ai, 1986) . Although there are several studies indicating that implantation-specific molecular changes occur in the uterine luminal epithelium, at the molecular level data are still lacking and the molecular nature of the membrane interactions at implantation is unclear at present. CellCAM-105 is a membrane-integrated, cell-surface glycoprotein, originally identified as being involved in intercellular adhesion of rat hepatocytes in vitro (Ocklind & Öbrink, 1982) . CellCAM- 105, isolated from the liver of the rat, consists of two highly glycosylated, structurally similar peptide chains of apparent M, 105 000 and 110 000, respectively (Odin et ai, 1986) . The molecule is expressed in several simple and stratified epithelia, platelets and granulocytes of the adult rat Odin et ai, 1988) . has been found on the surface of early, preimplantation blastocysts and of blastocysts in delay of implantation although the molecule disappears from the abembryonal trophectoderm of adhesive, implantation blastocysts (Svalander et ai, 1987 (Odin, 1987; Odin et ai, 1988) 
Materials and Methods
Antibodies. Affinity-purified rabbit IgG antibodies (anti-cellCAM antisera 7, 8, 9 and 10) against cellCAM-105 were used. The antisera were produced and affinity-purified as described previously (Odin et ai, 1986) . The specificity of the antibodies was determined by immunoprecipitation of 125I-labelled, detergent-solubilized rat hepatocytes followed by two-dimensional electrophoresis and autoradiography as described previously (Odin et ai, 1986) . All four anti-cellCAM IgG preparations were equally specific and reacted exclusively with the A-and B-chains of cellCAM-105 (Odin et ai, 1988 Experimental delay ofimplantation. Delay of implantation was induced as described previously (Svalander el ai, 1987) . Briefly, the rats were ovariectomized at Day 3 of pregnancy and injected every 5th day with 1 mg medroxyprogesterone acetate, ready-to-use immersion containing 50 mg hormone/ml (Depo-Provera; Upjohn Co., Puurs, Belgium). Reactivation from delay was induced by injecting 01 pg oestradiol-17ß (Sigma Chemical Co., St Louis, MO, USA) dissolved in polypropylene glycol at a concentration of 1 pg/ml. The adhesion stage of implantation is reached 18 h after oestrogen injection (Bergström, 1978 Endogeneous peroxidase activity was inhibited routinely by incubating the rehydrated sections in 3% hydrogen peroxide in tap water for 20 min. Non-specific antibody adsorption was reduced by incubation in 1 % normal pig serum (NSS) and 01% bovine serum albumin (BSA) in PBS-D for 3 h in a moist chamber.
After the blocking treatment, the sections were incubated in 75 pi of affinity-purified anti-cellCAM IgG antibodies or preimmune-IgG in 1 % NSS and 0-1 % BSA in PBS-D for 60 min at room temperature in a moist chamber. The antibody was tested at concentrations of 3-5, 17 and 34 pg/ml. The slides were washed in PBS-D three times each lasting 10 min. The excess liquid was then blotted from the slides and the sections were incubated for 20 min at room temperature in a moist chamber in 75 pi biotinylated pig anti-rabbit immunoglobulin (Dakopatts A/S, Glostrup, Denmark), diluted 1:200 in 1% NSS and 01% BSA in PBS-D. Washing was repeated and the sections incubated for 30 min at room temperature in a moist chamber in 75 pi ABC reagent (Vectastain; Vector Laboratories Inc., Burlingame, CA, USA). The ABC reagent was prepared according to the manufacturer's instructions. The slides were then washed in PBS-D three times each lasting 10 min and incubated for 15 min in a substrate solution prepared immediately before use by mixing 10 mg 3-amino-9-ethylcarbazole (Sigma) dissolved in 6 ml dimethylsulphoxide (DMSO) with 50 ml 20 mM-sodium acetate buffer, pH 5-5, and adding 4 pi 30% H202. After washing in tap water, the sections were counterstained with Mayer's haematoxylin, then washed in tap water and mounted in Kaiser's glyceringelatin. The sections were examined by light microscopy immediately after mounting and then stored in the dark at room temperature for subsequent re-examination. The results were based on the examination of immunohistochemi¬ cal staining of at least 80 random, transverse sections of each uterine specimen. The examination was performed independently by two investigators.
Immunohistochemical controls. All samples were checked for non-specific antibody adsorption, endogenous per¬ oxidase activity, and endogenous avidin-binding activity. Parallel sections were incubated for ABC staining (1) with an equal amount of the corresponding preimmune-IgG antibody, isolated by affinity chromatography on protein ASepharose (Ocklind & Öbrink, 1982) , and (2) without any Ig. Endogenous avidin-binding activity was also tested for by incubating parallel sections in 01% avidin followed by 001% biotin (Wood & Warnke, 1981) (Fig. 2a-d) . CellCAM-staining was observed in the uterine luminal epithelium only at the pro-oestrous (Fig. 2a) and oestrous stages (Fig. 2b) . The uterine glandular epithelium was simultaneously cellCAM-negative. The uterine glandular epithelium exhibited cellCAM staining only in the dioestrous stage (Fig. 2d) . Fig. 2h ). CellCAM-105 was detected in the luminal epithelium only after 5 consecutive daily doses of oestrogen, but was not detected in the glandular epithelium (Table 1) . (arrow) whereas the luminal epithelium is negative, 1100. (e) Day 7 of normal pregnancy: the uterine glandular epithelium is cellCAM-positive (arrow) whereas the luminal epithelium is negative, 400. (f) Day-8 implanting blastocyst: all embryonic cells and the luminal epithelium are devoid of staining (the ectoplacental cone trophoblast is located to the right), the glandular epithelium is not shown but had cellCAM-staining. 400. (g) Uterus of an ovariectomized rat without hormone treatment: staining for cellCAM is absent, 400. (h) Uterus of an ovariectomized rat treated with one dose (1 mg) of progesterone: the glandular epithelium is stained (arrow) whereas the luminal epithelium is devoid of staining, 400.
CellCAM-105 in juvenile rats after treatment with ovarian steroid hormones. CellCAM staining occurred both in the uterine luminal and glandular epithelium of untreated juvenile rats and this pattern of staining was unaffected by injection of oestrogen. However, the injection of pro¬ gesterone, alone or in combination with 2 doses of oestrogen, resulted in the disappearance of cellCAM-105 from the luminal epithelium, but not from the glandular epithelium (Table 1) .
Immunohistochemical controls. All controls were negative.
Discussion
Immunochemical and immunohistochemical studies of cellCAM-105 have revealed that this molecule is preferentially expressed by stationary, terminally differentiated, or differentiating cells (Odin et ai, 1988; . We have proposed that the molecule may be involved in the organization of the structure of the normal liver and of certain epithelia into their mature patterns (Odin et ai, 1988 . In transplantable rat hepatocellular carcinomas, cellCAM-105 is absent or chemically modified (Hixson et ai, 1985) .
Biochemical identification of cellCAM-105 in the uterus of the rat has been conducted pre¬ viously by a quantitative radioimmunoassay, and by SDS-polyacrylamide gel electrophoresis and immunoblotting with affinity-purified anti-cellCAM IgG (Odin, 1987; Odin et ai, 1988) . Four different anti-cellCAM antibodies yielded identical patterns: a single, rather broad band appeared with a mean apparent molecular weight of 105 000 (96 000-117 000) under non-reducing conditions. This apparent Mr was slightly higher than that of cellCAM-105 in the liver, indicating minor macromolecular differences between liver-cell CAM and uterus-cell CAM. The differences may reside in the carbohydrate and/or the peptide part of the molecule and might reflect differences in functional properties.
In the present work, we found that the expression of cellCAM-105 in the uterus changed dynamically during the reproductive cycle. Furthermore, the pattern of expression differed in the luminal and the glandular epithelia, respectively. These fluctuations could be mimicked by injection of ovarian steroid hormones. The luminal epithelium expressed cellCAM-105 in response to oestrogen, whereas the glandular epithelium expressed cellCAM-105 in response to progesterone. Progesterone was also found to induce a down-regulation of cellCAM-105 from the uterine luminal epithelium.
Accordingly, it seems likely that the expression of this molecule is influenced by the fluctuating concentrations of progesterone and oestrogen occurring during the reproductive cycle. CellCAM-105 appeared in the glandular epithelium in correlation with the two peak levels of progesterone, namely at dioestrus and around Day 1 of pregnancy (Hashimoto et ai, 1968) , at both of which oestrogen is low. The reappearance of cellCAM-105 in the glandular epithelium at the time of implantation may be due to the rise in progesterone or to a synergistic effect of oestrogen and progesterone. In the luminal epithelium the cellCAM-105 expression correlated with the peak of oestrogen during pro-oestrus and oestrus, and during the first day of pregnancy. The disappearance of cellCAM-105 from the luminal epithelium correlated with high progesterone concentrations during met-and dioestrus, and from Day 3 of pregnancy onwards.
Previous studies in the rat have shown that differences in the response to ovarian hormones exist in the uterine luminal and glandular epithelia (for review, see Finn & Porter, 1975 (Hsueh et ai, 1975 (Cowell, 1969) , but are capable of implantation at extrauterine sites (Fawcett, 1950; Kirby, 1963a, b) regardless of the hormonal environment. It is possible that the apical surface of the non-receptive uterine luminal epithelium expresses molecules which prevent the blastocyst from invading the uterus. It therefore seems relevant to assume that ovarian steroid hormones induce specific molecular changes in the luminal surface of the uterus to allow the trophoblast to adhere to and then to penetrate and invade the endometrium. The changes in expression of cellCAM-105 in the luminal epithelium could be part of such a mechanism. The disappearance of cellCAM-105 may result in fewer cross-linked cell surfaces which might facilitate cellular dissociation and motility necessary for the penetration and invasion of the uterine luminal epithelium by the trophectodermal cells at implantation.
